TAKEDA PHARM.CO.LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of TKD for the last quarter is 7.35 B EUR, and it's 4.89% higher compared to the previous quarter. The net income of Q2 24 is 575.14 M EUR.